Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 4 Study to Expand Access Program While Assessing the Safety and Efficacy of Paromomycin IM Injection in an Outpatient Setting for the Treatment of Visceral Leishmaniasis

NCT00604955 is registered in ClinicalTrials.gov with PATH as lead sponsor.

NCT NCT00604955
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00604955 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 4 Study to Expand Access Program While Assessing the Safety and Efficacy of Paromomycin IM Injection in an Outpatient Setting for the Treatment of Visceral Leishmaniasis
Lead sponsor
PATH
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2007
Completion date
January 31, 2010
Enrollment
2,000 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

visceral leishmaniasis